Hong Kong-listed company Huajian Medical (stock code: 01931.HK) recently announced that the company has successfully completed the acquisition of a property in Irvine, Orange County, California, USA, with a total transaction price of US$4.365 million.
The acquisition of this property marks a substantial step forward for Huajian Medical in expanding its international asset layout.
At the same time, to further promote the group's business development in North America, Huajian Medical has registered a wholly-owned subsidiary in Colorado, USA - ETHKBANK Inc. (registration ID: 20251886812).
The company will serve as the core platform for Huajian Medical to carry out a number of innovative businesses in the North American market, focusing on cutting-edge fields such as stablecoin-related businesses, the healthcare industry, and the securitization of innovative drug intellectual property rights.
This property acquisition and the establishment of an overseas subsidiary are important measures for Huajian Medical to implement its internationalization strategy and actively explore emerging business models.
In the future, ETHKBANK will leverage the group's accumulated resources and technological advantages in the medical field, combined with the mature environment of the North American market in digital assets and financial innovation, to help Huajian Medical build a more diversified business ecosystem globally.